메뉴 건너뛰기




Volumn 29, Issue 48, 2011, Pages 8888-8897

Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus

Author keywords

Antibody; B cells; Hemagglutinin; Immunology; Influenza virus; Vaccine

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN G; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT H5 HEMAGGLUTININ; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

EID: 82455188114     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.069     Document Type: Article
Times cited : (9)

References (45)
  • 1
    • 0031578614 scopus 로고    scopus 로고
    • Isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep (December (50))
    • Isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep 1997;46 (December (50)):1204-7.
    • (1997) , vol.46 , pp. 1204-1207
  • 2
    • 14444284599 scopus 로고    scopus 로고
    • Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness
    • Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279(January (5349)):393-396.
    • (1998) Science , vol.279 , pp. 393-396
    • Subbarao, K.1    Klimov, A.2    Katz, J.3    Regnery, H.4    Lim, W.5    Hall, H.6
  • 4
    • 84857907948 scopus 로고    scopus 로고
    • WHO. H5N1 avian influenza: timeline of major events; Available from
    • WHO. H5N1 avian influenza: timeline of major events; 2010. Available from http://www.who.int/csr/disease/avian_influenza/ai_timeline/en/index.html.
    • (2010)
  • 5
    • 84857903227 scopus 로고    scopus 로고
    • WHO. Confirmed cases of avian influenza A (H5N1); Available from
    • WHO. Confirmed cases of avian influenza A (H5N1); 2010. Available from http://www.who.int/csr/disease/avian_influenza/country/en/.
    • (2010)
  • 6
    • 13744258437 scopus 로고    scopus 로고
    • Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma
    • de Jong M.D., Cam B.V., Qui P.T., Hien V.M., Thanh T.T., Hue N.B., et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005, 352(7):686-691.
    • (2005) N Engl J Med , vol.352 , Issue.7 , pp. 686-691
    • de Jong, M.D.1    Cam, B.V.2    Qui, P.T.3    Hien, V.M.4    Thanh, T.T.5    Hue, N.B.6
  • 7
    • 33749511112 scopus 로고    scopus 로고
    • Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
    • de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J.D., Chau T.N.B., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12(10):1203-1207.
    • (2006) Nat Med , vol.12 , Issue.10 , pp. 1203-1207
    • de Jong, M.D.1    Simmons, C.P.2    Thanh, T.T.3    Hien, V.M.4    Smith, G.J.D.5    Chau, T.N.B.6
  • 8
    • 34648840650 scopus 로고    scopus 로고
    • H5N1 infection of the respiratory tract and beyond: a molecular pathology study
    • Gu J., Xie Z., Gao Z., Liu J., Korteweg C., Ye J., et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007, 370(9593):1137-1145.
    • (2007) Lancet , vol.370 , Issue.9593 , pp. 1137-1145
    • Gu, J.1    Xie, Z.2    Gao, Z.3    Liu, J.4    Korteweg, C.5    Ye, J.6
  • 11
    • 84857896782 scopus 로고    scopus 로고
    • WHO. Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses;. Available from
    • WHO. Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses; 2009. Available from http://www.who.int/csr/disease/avian_influenza/guidelines/nomenclature/en/index.html.
    • (2009)
  • 12
    • 39749087048 scopus 로고    scopus 로고
    • Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus
    • Starick E., Beer M., Hoffmann B., Staubach C., Werner O., Globig A., et al. Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus. Vet Microbiol 2008, 128(April (3-4)):243-252.
    • (2008) Vet Microbiol , vol.128 , pp. 243-252
    • Starick, E.1    Beer, M.2    Hoffmann, B.3    Staubach, C.4    Werner, O.5    Globig, A.6
  • 14
    • 54049093185 scopus 로고    scopus 로고
    • Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006
    • Kiss I., Gyarmati P., Zohari S., Ramsay K.W., Metreveli G., Weiss E., et al. Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J 2008, 5:113.
    • (2008) Virol J , vol.5 , pp. 113
    • Kiss, I.1    Gyarmati, P.2    Zohari, S.3    Ramsay, K.W.4    Metreveli, G.5    Weiss, E.6
  • 15
    • 34047147320 scopus 로고    scopus 로고
    • Genetic characterization of HPAI (H5N1) viruses from poultry and wild vultures, Burkina Faso
    • Ducatez M.F., Tarnagda Z., Tahita M.C., Sow A., de Landtsheer S., Londt B.Z., et al. Genetic characterization of HPAI (H5N1) viruses from poultry and wild vultures, Burkina Faso. Emerg Infect Dis 2007, 13(April (4)):611-613.
    • (2007) Emerg Infect Dis , vol.13 , pp. 611-613
    • Ducatez, M.F.1    Tarnagda, Z.2    Tahita, M.C.3    Sow, A.4    de Landtsheer, S.5    Londt, B.Z.6
  • 16
    • 33750286032 scopus 로고    scopus 로고
    • Vaccines for seasonal and pandemic influenza
    • Nichol K.L., Treanor J.J. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006, 194(November (Suppl. 2)):S111-S118.
    • (2006) J Infect Dis , vol.194
    • Nichol, K.L.1    Treanor, J.J.2
  • 17
    • 0013945945 scopus 로고
    • Disquisitions on original antigenic sin. II. Proof in lower creatures
    • Fazekas de St G., Webster R.G. Disquisitions on original antigenic sin. II. Proof in lower creatures. J Exp Med 1966, 124(September (3)):347-361.
    • (1966) J Exp Med , vol.124 , pp. 347-361
    • Fazekas de St, G.1    Webster, R.G.2
  • 18
    • 0013950605 scopus 로고
    • Disquisitions of original antigenic sin. I Evidence in man
    • Fazekas de St G., Webster R.G. Disquisitions of original antigenic sin. I Evidence in man. J Exp Med 1966, 124(September (3)):331-345.
    • (1966) J Exp Med , vol.124 , pp. 331-345
    • Fazekas de St, G.1    Webster, R.G.2
  • 19
    • 70349237173 scopus 로고    scopus 로고
    • Original antigenic sin responses to influenza viruses
    • Kim J.H., Skountzou I., Compans R., Jacob J. Original antigenic sin responses to influenza viruses. J Immunol 2009, 183(September (5)):3294-3301.
    • (2009) J Immunol , vol.183 , pp. 3294-3301
    • Kim, J.H.1    Skountzou, I.2    Compans, R.3    Jacob, J.4
  • 20
    • 50949099930 scopus 로고    scopus 로고
    • Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
    • Goji N.A., Nolan C., Hill H., Wolff M., Noah D.L., Williams T.B., et al. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis 2008, 198(September (5)):635-641.
    • (2008) J Infect Dis , vol.198 , pp. 635-641
    • Goji, N.A.1    Nolan, C.2    Hill, H.3    Wolff, M.4    Noah, D.L.5    Williams, T.B.6
  • 21
    • 82455214553 scopus 로고    scopus 로고
    • B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant
    • Baer J., Santiago F., Yang H., Wu H., Holden-Wiltse J., Treanor J., et al. B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant. Vaccine 2009, (November).
    • (2009) Vaccine
    • Baer, J.1    Santiago, F.2    Yang, H.3    Wu, H.4    Holden-Wiltse, J.5    Treanor, J.6
  • 22
    • 63849240274 scopus 로고    scopus 로고
    • Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
    • Smith K., Garman L., Wrammert J., Zheng N.Y., Capra J.D., Ahmed R., et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 2009, 4(3):372-384.
    • (2009) Nat Protoc , vol.4 , Issue.3 , pp. 372-384
    • Smith, K.1    Garman, L.2    Wrammert, J.3    Zheng, N.Y.4    Capra, J.D.5    Ahmed, R.6
  • 23
    • 77954386670 scopus 로고    scopus 로고
    • Recombinant proteins produced in insect cells
    • Treanor J. Recombinant proteins produced in insect cells. Curr Top Microbiol Immunol 2009, 333:211-225.
    • (2009) Curr Top Microbiol Immunol , vol.333 , pp. 211-225
    • Treanor, J.1
  • 24
    • 0029052912 scopus 로고
    • Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults
    • Powers D.C., Smith G.E., Anderson E.L., Kennedy D.J., Hackett C.S., Wilkinson B.E., et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis 1995, 171(June (6)):1595-1599.
    • (1995) J Infect Dis , vol.171 , pp. 1595-1599
    • Powers, D.C.1    Smith, G.E.2    Anderson, E.L.3    Kennedy, D.J.4    Hackett, C.S.5    Wilkinson, B.E.6
  • 25
    • 0029837041 scopus 로고    scopus 로고
    • Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults
    • Lakey D.L., Treanor J.J., Betts R.F., Smith G.E., Thompson J., Sannella E., et al. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis 1996, 174(October (4)):838-841.
    • (1996) J Infect Dis , vol.174 , pp. 838-841
    • Lakey, D.L.1    Treanor, J.J.2    Betts, R.F.3    Smith, G.E.4    Thompson, J.5    Sannella, E.6
  • 26
    • 0033538014 scopus 로고    scopus 로고
    • Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine
    • Johansson B.E. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 1999, 17(April (15-16)):2073-2080.
    • (1999) Vaccine , vol.17 , pp. 2073-2080
    • Johansson, B.E.1
  • 28
    • 24644454633 scopus 로고    scopus 로고
    • Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines
    • Hoffmann E., Lipatov A.S., Webby R.J., Govorkova E.A., Webster R.G. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc Natl Acad Sci U S A 2005, 102(September (36)):12915-12920.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 12915-12920
    • Hoffmann, E.1    Lipatov, A.S.2    Webby, R.J.3    Govorkova, E.A.4    Webster, R.G.5
  • 29
    • 2442440593 scopus 로고    scopus 로고
    • Immunogenicity and protective efficacy of influenza vaccination
    • Hannoun C., Megas F., Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004, 103(July (1-2)):133-138.
    • (2004) Virus Res , vol.103 , pp. 133-138
    • Hannoun, C.1    Megas, F.2    Piercy, J.3
  • 30
    • 0015452705 scopus 로고
    • The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
    • Hobson RLC D., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg 1972, 70:767-777.
    • (1972) J Hyg , vol.70 , pp. 767-777
    • Hobson, D.1    Curry, R.L.2    Beare, A.S.3    Ward-Gardner, A.4
  • 31
    • 82455177343 scopus 로고    scopus 로고
    • CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep
    • CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 2010: 1-62.
    • (2010) , pp. 1-62
  • 32
    • 38849209040 scopus 로고    scopus 로고
    • Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine
    • Baras B., Stittelaar K.J., Simon J.H., Thoolen R.J., Mossman S.P., Pistoor F.H., et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS One 2008, 3(1):e1401.
    • (2008) PLoS One , vol.3 , Issue.1
    • Baras, B.1    Stittelaar, K.J.2    Simon, J.H.3    Thoolen, R.J.4    Mossman, S.P.5    Pistoor, F.H.6
  • 33
    • 78651396311 scopus 로고    scopus 로고
    • Bacterial HA1 vaccine against pandemic h5n1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets
    • Khurana S., Verma S., Verma N., Crevar C.J., Carter D.M., Manischewitz J., et al. Bacterial HA1 vaccine against pandemic h5n1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. J Virol 2011, 85(February (3)):1246-1256.
    • (2011) J Virol , vol.85 , pp. 1246-1256
    • Khurana, S.1    Verma, S.2    Verma, N.3    Crevar, C.J.4    Carter, D.M.5    Manischewitz, J.6
  • 34
    • 23844534838 scopus 로고    scopus 로고
    • Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system
    • Brett I.C., Johansson B.E. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 2005, 339(September (2)):273-280.
    • (2005) Virology , vol.339 , pp. 273-280
    • Brett, I.C.1    Johansson, B.E.2
  • 35
    • 70349781658 scopus 로고    scopus 로고
    • Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
    • Biesova Z., Miller M.A., Schneerson R., Shiloach J., Green K.Y., Robbins J.B., et al. Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine 2009, 27(October (44)):6234-6238.
    • (2009) Vaccine , vol.27 , pp. 6234-6238
    • Biesova, Z.1    Miller, M.A.2    Schneerson, R.3    Shiloach, J.4    Green, K.Y.5    Robbins, J.B.6
  • 36
    • 45749084541 scopus 로고    scopus 로고
    • Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus
    • Wei C.J., Xu L., Kong W.P., Shi W., Canis K., Stevens J., et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 2008, 82(July (13)):6200-6208.
    • (2008) J Virol , vol.82 , pp. 6200-6208
    • Wei, C.J.1    Xu, L.2    Kong, W.P.3    Shi, W.4    Canis, K.5    Stevens, J.6
  • 37
    • 79751471067 scopus 로고    scopus 로고
    • Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant
    • Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, et al. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis 2011;203(March (5)):666-73.
    • (2011) J Infect Dis , vol.203 , pp. 666-673
    • Belshe, R.B.1    Frey, S.E.2    Graham, I.3    Mulligan, M.J.4    Edupuganti, S.5    Jackson, L.A.6
  • 38
    • 33748993450 scopus 로고    scopus 로고
    • Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
    • Suguitan A.L., McAuliffe J., Mills K.L., Jin H., Duke G., Lu B., et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 2006, 3(September (9)):e360.
    • (2006) PLoS Med , vol.3
    • Suguitan, A.L.1    McAuliffe, J.2    Mills, K.L.3    Jin, H.4    Duke, G.5    Lu, B.6
  • 39
    • 71149099301 scopus 로고    scopus 로고
    • Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model
    • Sabarth N., Howard M.K., Savidis-Dacho H., van Maurik A., Barrett P.N., Kistner O. Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. Vaccine 2010, 28(January (3)):650-656.
    • (2010) Vaccine , vol.28 , pp. 650-656
    • Sabarth, N.1    Howard, M.K.2    Savidis-Dacho, H.3    van Maurik, A.4    Barrett, P.N.5    Kistner, O.6
  • 40
    • 77956837160 scopus 로고    scopus 로고
    • Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A (H1N1) influenza virus infection in ferrets
    • Bosch B.J., Bodewes R., de Vries R.P., Kreijtz J.H.C.M., Bartelink W., van Amerongen G., et al. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A (H1N1) influenza virus infection in ferrets. J Virol 2010, 84(October (19)):10366-10374.
    • (2010) J Virol , vol.84 , pp. 10366-10374
    • Bosch, B.J.1    Bodewes, R.2    de Vries, R.P.3    Kreijtz, J.H.C.M.4    Bartelink, W.5    van Amerongen, G.6
  • 41
    • 0017926660 scopus 로고
    • Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection
    • Verbonitz M.W., Ennis F.A., Hicks J.T., Albrecht P. Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection. J Exp Med 1978, 147(January (1)):265-270.
    • (1978) J Exp Med , vol.147 , pp. 265-270
    • Verbonitz, M.W.1    Ennis, F.A.2    Hicks, J.T.3    Albrecht, P.4
  • 42
    • 0021037896 scopus 로고
    • Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
    • Hashimoto G., Wright P.F., Karzon D.T. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis 1983, 148(November (5)):785-794.
    • (1983) J Infect Dis , vol.148 , pp. 785-794
    • Hashimoto, G.1    Wright, P.F.2    Karzon, D.T.3
  • 43
    • 0025736372 scopus 로고
    • Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry
    • Tamura M., Webster R.G., Ennis F.A. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology 1991, 182(May (1)):211-219.
    • (1991) Virology , vol.182 , pp. 211-219
    • Tamura, M.1    Webster, R.G.2    Ennis, F.A.3
  • 44
    • 12344325450 scopus 로고    scopus 로고
    • Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination
    • Gulati U., Kumari K., Wu W., Keitel W.A., Air G.M. Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine 2005, 23(11):1414-1425.
    • (2005) Vaccine , vol.23 , Issue.11 , pp. 1414-1425
    • Gulati, U.1    Kumari, K.2    Wu, W.3    Keitel, W.A.4    Air, G.M.5
  • 45
    • 44449118948 scopus 로고    scopus 로고
    • Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
    • Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453(7195):667-671.
    • (2008) Nature , vol.453 , Issue.7195 , pp. 667-671
    • Wrammert, J.1    Smith, K.2    Miller, J.3    Langley, W.A.4    Kokko, K.5    Larsen, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.